Keyphrases
CYP2C19 Polymorphism
91%
CYP2C19
66%
Percutaneous Coronary Intervention
64%
Genotype-guided Antiplatelet Therapy
56%
Antiplatelet Therapy
48%
Precision Medicine
32%
Selective Serotonin Reuptake Inhibitors
32%
Alternative Therapy
32%
Pharmacogenetics
30%
Therapy Selection
29%
Reusability
27%
Genotype Data
27%
Clopidogrel
25%
Gain-of-function mutation
23%
Electronic Health Records
20%
Clinical Decision Support
20%
Confidence Interval
19%
Antidepressants
18%
Adverse Drug Reaction
18%
Genotype
17%
Cytochrome P450 2D6 (CYP2D6)
17%
Bleeding
17%
P2Y12 Inhibitors
16%
Cardiovascular Events
15%
Clinical Pharmacogenetics Implementation Consortium
13%
Retrospective Cohort Study
13%
SLC6A4
13%
Serotonin Reuptake Inhibitor Antidepressants
13%
Pain Management
13%
Clinical Practice
13%
Genetic Determinants
13%
Antiepileptic Drugs
13%
Bleeding Outcomes
13%
Racial Disparities
13%
Drug Therapy
13%
Clinical Setting
13%
Treatment Response
13%
Risk Factors
13%
Therapy Outcome
13%
Pharmacogenomics
13%
Targeted Drugs
13%
Anti-dementia Drugs
13%
Machine Learning
13%
HTR2A
13%
Clinical Considerations
13%
Targeted Treatment
13%
Cardiovascular Outcomes
13%
Opioid Epidemic
13%
Warfarin Pharmacogenetics
13%
Sexual Dysfunction
13%
Medicine and Dentistry
CYP2C19
100%
Antiplatelet
89%
Percutaneous Coronary Intervention
51%
Allele
47%
Drug Therapy
32%
Medicine
27%
Clopidogrel
26%
Genotype
25%
Pharmacogenetics
17%
Electronic Health Record
15%
Prasugrel
15%
Ticagrelor
15%
Cardiovascular System
15%
Personalized Medicine
13%
Adverse Drug Reaction
13%
Epidemic
13%
Racial Disparity
13%
Genetic Selection
13%
Opiate
13%
Isoenzyme
13%
Bleeding
13%
Selective Serotonin Reuptake Inhibitor
13%
COVID-19
13%
Pharmacogenetic Testing
13%
Hazard Ratio
12%
Antidepressant
10%
Pharmacogenomics
8%
Ciclonicate
8%
CYP2D6
7%
Clinician
6%
Odds Ratio
6%
Analgesia
6%
Prospective Study
6%
Major Bleeding
5%
Pharmacology, Toxicology and Pharmaceutical Science
CYP2C19
87%
Antiplatelet
79%
Clopidogrel
48%
Selective Serotonin Reuptake Inhibitor
41%
Pharmacogenetics
30%
Pharmacogenomics
29%
Bleeding
19%
Prasugrel
17%
Ticagrelor
17%
Adverse Drug Reaction
16%
Cohort Study
15%
Disease
13%
Alzheimer's Disease
13%
Tolerability
13%
Coronavirinae
13%
Isoenzyme
13%
Warfarin
13%
Heart Arrhythmia
13%
Serotonin Transporter
13%
Antidepressant
11%
Mirtazapine
10%
Cardiovascular Disease
10%
Adverse Event
9%
HLA B15 Antigen
8%
Major Adverse Cardiac Event
8%
Heart Infarction
7%
Ciclonicate
5%
CYP2D6
5%
Prospective Study
5%